Cargando…

Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer

BACKGROUND: Tumour budding is a histological finding in epithelial cancers indicating an unfavourable phenotype. Previous studies have demonstrated that it is a negative prognostic indicator in colorectal cancer (CRC), and has been proposed as an additional factor to incorporate into staging protoco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rogers, A C, Winter, D C, Heeney, A, Gibbons, D, Lugli, A, Puppa, G, Sheahan, K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5046217/ https://www.ncbi.nlm.nih.gov/pubmed/27599041 http://dx.doi.org/10.1038/bjc.2016.274

Ejemplares similares

CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a ‘pro-/anti-tumour’ approach to tumour host interaction in colorectal cancer
por: Lugli, A, et al.
Publicado: (2009)

Tumour budding in oral squamous cell carcinoma: a meta-analysis
por: Almangush, Alhadi, et al.
Publicado: (2018)

Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer
por: Galván, J A, et al.
Publicado: (2015)

The relationship between tumour budding, the tumour microenvironment and survival in patients with invasive ductal breast cancer
por: Gujam, F J A, et al.
Publicado: (2015)

Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis
por: Mei, Z, et al.
Publicado: (2014)

Tumour microenvironment of both early- and late-stage colorectal cancer is equally immunosuppressive
por: O'Toole, A, et al.
Publicado: (2014)

Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients
por: Zlobec, I, et al.
Publicado: (2014)

Tumour budding at the deepest invasive margin correlates with lymph node metastasis in submucosal colorectal cancer detected by anticytokeratin antibody CAM5.2
por: Kazama, S, et al.
Publicado: (2006)

PRL-3 is essentially overexpressed in primary colorectal tumours and associates with tumour aggressiveness
por: Molleví, D G, et al.
Publicado: (2008)

The in situ local immune response, tumour senescence and proliferation in colorectal cancer
por: Roxburgh, C S, et al.
Publicado: (2013)

Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy
por: Zlobec, I, et al.
Publicado: (2008)

Dichloroacetate induces autophagy in colorectal cancer cells and tumours
por: Lin, G, et al.
Publicado: (2014)

Tumour-site-dependent expression profile of angiogenic factors in tumour-associated stroma of primary colorectal cancer and metastases
por: Kahlert, C, et al.
Publicado: (2014)

Tumour invasiveness, the local and systemic environment and the basis of staging systems in colorectal cancer
por: Park, J H, et al.
Publicado: (2017)

Tumour gene expression predicts response to cetuximab in patients with KRAS wild-type metastatic colorectal cancer
por: Baker, J B, et al.
Publicado: (2011)

Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching
por: De Smedt, Linde, et al.
Publicado: (2017)

A simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy
por: Zlobec, I, et al.
Publicado: (2007)

Clinical significance of CDX2-positive circulating tumour cells in colorectal cancer patients
por: Wong, S C C, et al.
Publicado: (2011)

The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
por: Gooden, M J M, et al.
Publicado: (2011)

Geographic analysis of RKIP expression and its clinical relevance in colorectal cancer
por: Koelzer, V H, et al.
Publicado: (2013)

Multi-level evidence that circulating CK18 is a biomarker of tumour burden in colorectal cancer
por: Greystoke, A, et al.
Publicado: (2012)

Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II–III colorectal cancer
por: Chaput, N, et al.
Publicado: (2013)

Pyrosequencing-based methods reveal marked inter-individual differences in oncogene mutation burden in human colorectal tumours
por: Weidlich, S, et al.
Publicado: (2011)

Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia
por: Koukourakis, M I, et al.
Publicado: (2010)

FOXO3 expression during colorectal cancer progression: biomarker potential reflects a tumour suppressor role
por: Bullock, M D, et al.
Publicado: (2013)

Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer
por: Ngan, C Y, et al.
Publicado: (2007)

Tumour-suppressive function of SIRT4 in human colorectal cancer
por: Miyo, M, et al.
Publicado: (2015)

The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients
por: West, N P, et al.
Publicado: (2010)

Prognostic value of circulating tumour cells for early recurrence after resection of colorectal liver metastases
por: Lalmahomed, Z S, et al.
Publicado: (2015)

Circulating IL-6 concentrations link tumour necrosis and systemic and local inflammatory responses in patients undergoing resection for colorectal cancer
por: Guthrie, G J K, et al.
Publicado: (2013)

Thrombomodulin expression in colorectal carcinoma is protective and correlates with survival
por: Hanly, A M, et al.
Publicado: (2006)

Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic review
por: Grønhøj Larsen, C, et al.
Publicado: (2014)

Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer
por: Lugli, A, et al.
Publicado: (2010)

Molecular patterns in deficient mismatch repair colorectal tumours: results from a French prospective multicentric biological and genetic study
por: Etienne-Grimaldi, M-C, et al.
Publicado: (2014)

Mismatch repair status in patients with primary operable colorectal cancer: associations with the local and systemic tumour environment
por: Park, James H, et al.
Publicado: (2016)

KRAS mutations in primary tumours and post-FOLFOX metastatic lesions in cases of colorectal cancer
por: Kawamoto, Y, et al.
Publicado: (2012)

Disseminated tumour cells as a prognostic biomarker in colorectal cancer
por: Flatmark, K, et al.
Publicado: (2011)

High levels of cleaved caspase-3 in colorectal tumour stroma predict good survival
por: Noble, P, et al.
Publicado: (2013)

KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients
por: Knijn, N, et al.
Publicado: (2011)

MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1
por: Feng, Y, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2v8iecpgchunh0qg887g1jlf37